경계성 투명세포섬유선종 1예
A case of borderline clear cell fibroadenoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
난소의 투명세포종양은 드물고, 그 중 5~8%가 난소의 투명세포 섬유선종에 해당하며, 경계성 투명세포종양은 경계성 난소종양의 <1%로 드문 질환이다. 경계성 투명세포 섬유선종은 중년의 여성에게서 호발하고, 대부분 비특이적 증상을 호소한다. 경계성 투명세포 섬유선종은 발생 빈도가 매우 낮아 생물학적 형태에 대하여 거의 알려진 바가 없고 효과적인 치료방법에 대해서도 일치된 의견이 없다. 본 저자들은 동결절편검사상 난소 섬유선종으로 오인한 경계성 투명세포섬유선종 1예를 경험하였기에 간단한 문헌고찰과 함께 보고하는 바이다.
Abstract
Clear cell tumor of borderline malignancy has been reported to account for 5 to 8% of all clear cell neoplasms, and <1% of borderline malignancies of the ovary. Borderline clear cell fibroadenoma with or without microinvasion mostly occurs in women with middle age, and the presenting symptoms associated with this tumor are non‐specific. The clinico‐pathologic features of borderline clear cell fibroadenoma are not well known because of its rarity. Furthermore, there is no consensus for treating the disease. Thus, we report a case of borderline clear cell fibroadenoma presenting as ovarian fibroadenoma with a review of literature.
참고문헌 (15)
- Ryu SY, "Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective study of Korean Gynecologic Oncology Group", Ann Oncol, 20, pp.1032~1036 (2009)
- Yamamoto S, "Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathwa", J Pathol, 216, pp.103~110 (2008)
- Bell DA, "Benign and borderline clear cell adenofibromas of the ovary", Cancer, 56, pp.2922~2931 (1985)
- Pasaoglu O, "Benign clear cell adenofibroma of the ovary. A case report with literature review", Gynecol Obstet Invest, 64, pp.36~39 (2007)
- Schiller W, "Parvilocular cystomas of the ovary; report of two cases", Obstet Gynecol, 10, pp.28~33 (1957)
- Roth LM, "Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma", Cancer, 53, pp.1156~1163 (1984)
- Kao GF, "Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types", Obstet Gynecol, 54, pp.729~736 (1979)
- Yamamoto S, "An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway", Virchows Arch, 455, pp.261~270 (2009)
- Randrianjafisamindrakotroka NS, "The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium. 118 cases including 13 proliferative and 5 carcinomatous", J Gynecol Obstet Biol Reprod (Paris), 22, pp.33~38 (1993)
- Veras E, "Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases", Am J Surg Pathol, 33, pp.844~853 (2009)
- Sugiyama T, "A pregnant woman with clear cell adenocarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types", Eur J Obstet Gynecol Reprod Biol, 72, pp.47~50 (1997)
- Marret H, "Sonographic diagnosis of ovarian tumors: pre-operative Doppler evaluation", J Radiol, 84, pp.1725~1731 (2003)
- Coumbos A, "Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany", Br J Cancer, 100, pp.1731~1738 (2009)
- Kokawa K, "Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years’ experience in the Kinki District of Japan (1990-2006)", Eur J Gynaecol Oncol, 30, pp.155~161 (2009)
- Rettenmaier MA, "Borderline ovarian tumors and extended patient follow-up: an individual institution’s experience", J Surg Oncol, 101, pp.18~21 (2010)